"synopsis" may belong to another edition of this title.
"About this title" may belong to another edition of this title.
Shipping:
£ 3.11
Within U.S.A.
Book Description Condition: New. Seller Inventory # ABLIING23Mar2811580148143
Book Description Taschenbuch. Condition: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Soon after the first description of monoclonal antibodies in 1976, there was enormous interest in the clinical application of antibodies, especially in the context of cancer. Antibodies appeared to offer the 'magic bullet' that would allow the specific destruction of neoplastic cells. H- ever, many years' effort resulted in very few cases of successful immu- therapy with antibodies. As a result there was a major backlash against antibody therapy, and the field lost a considerable amount of popularity. Fashion, in science as well as in other things, tends to be cyclical. Antibody-based therapy is once again attracting scientists and clinicians. There are several reasons for the renewed optimism; certainly the expe- ence of the last two decades has provided a wealth of information about problems associated with antibody therapy, and possible solutions to these problems. Recombinant antibody engineering has rejuvenated the field, allowing both the modification of antibodies to improve their in vivo pr- erties and the isolation of novel antibody molecules by such techniques as phage display. The results of recent clinical trials have demonstrated unequivocally the benefit of antibody therapy in a number of settings, and, finally, more careful consideration has been taken of the types of disease best treated using this approach. 492 pp. Englisch. Seller Inventory # 9781617371950
Book Description Soft Cover. Condition: new. Seller Inventory # 9781617371950
Book Description Condition: New. Seller Inventory # 4256699
Book Description Taschenbuch. Condition: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Soon after the first description of monoclonal antibodies in 1976, there was enormous interest in the clinical application of antibodies, especially in the context of cancer. Antibodies appeared to offer the 'magic bullet' that would allow the specific destruction of neoplastic cells. H- ever, many years' effort resulted in very few cases of successful immu- therapy with antibodies. As a result there was a major backlash against antibody therapy, and the field lost a considerable amount of popularity. Fashion, in science as well as in other things, tends to be cyclical. Antibody-based therapy is once again attracting scientists and clinicians. There are several reasons for the renewed optimism; certainly the expe- ence of the last two decades has provided a wealth of information about problems associated with antibody therapy, and possible solutions to these problems. Recombinant antibody engineering has rejuvenated the field, allowing both the modification of antibodies to improve their in vivo pr- erties and the isolation of novel antibody molecules by such techniques as phage display. The results of recent clinical trials have demonstrated unequivocally the benefit of antibody therapy in a number of settings, and, finally, more careful consideration has been taken of the types of disease best treated using this approach. Seller Inventory # 9781617371950
Book Description Condition: New. Editor(s): George, Andrew J.T.; Urch, Catherine E. Series: Methods in Molecular Medicine. Num Pages: 477 pages, biography. BIC Classification: MJCM. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 27. Weight in Grams: 717. . 2010. 1st ed. Softcover of orig. ed. 2000. Paperback. . . . . Seller Inventory # V9781617371950
Book Description Condition: New. PRINT ON DEMAND Book; New; Fast Shipping from the UK. No. book. Seller Inventory # ria9781617371950_lsuk
Book Description Condition: New. Editor(s): George, Andrew J.T.; Urch, Catherine E. Series: Methods in Molecular Medicine. Num Pages: 477 pages, biography. BIC Classification: MJCM. Category: (P) Professional & Vocational. Dimension: 229 x 152 x 27. Weight in Grams: 717. . 2010. 1st ed. Softcover of orig. ed. 2000. Paperback. . . . . Books ship from the US and Ireland. Seller Inventory # V9781617371950